Chloroacetyl isocyanate → 7-chloro-N-chloracetyl-5-(o-chlorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine-1-carboxamide

HRID 1706613ノート

反応式

HRID 1706613 の反応式
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[NH:11][CH2:10][CH2:9][N:8]=[C:7]([C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[Cl:18])[C:6]=2[CH:19]=1.[Cl:20][CH2:21][C:22]([N:24]=[C:25]=[O:26])=[O:23]>C(Cl)Cl>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([C:25]([NH:24][C:22](=[O:23])[CH2:21][Cl:20])=[O:26])[CH2:10][CH2:9][N:8]=[C:7]([C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[Cl:18])[C:6]=2[CH:19]=1

参加物

4

反応物 2

HCID 78209Chloroacetyl isocyanateHCID 20333776HCID 20333776、化合物

生成物 1

HCID 203337737-chloro-N-chloracetyl-5-(o-chlorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine-1-carboxamide

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

The mixture of 8 parts of 7-chloro-5-(o-chlorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine, 4.9 parts of chloroacetylisocyanate, and 200 parts by volume of methylene chloride is stirred under nitrogen atmosphere at ambient temperature for about one hour. The mixture is then filtered through a layer of activated magnesium silicate and the filtrate evaporated to dryness. The resultant yellow oil is dissolved in ether and the solvent removed by evaporation to give gummy residue which upon crystallization from ether affords 7-chloro-N-chloracetyl-5-(o-chlorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine-1-carboxamide, as a yellow solid melting at about 152°-156° C. This compound is represented by the following formula ##STR21##

後処理

  1. filtrationThe mixture is then filtered through a layer of activated magnesium silicate
  2. customthe filtrate evaporated to dryness
  3. dissolutionThe resultant yellow oil is dissolved in ether
  4. customthe solvent removed by evaporation
  5. customto give gummy residue which
  6. customupon crystallization from ether

出典と根拠

ORDレコード
ord-380e3946dc8e4869a061b8e7e1e53b64
出典データセット
uspto-grants-1980_06
特許番号
US04208327

反応ノート

読み込み中…